In 2025, Aspen Pharmacare Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Aspen Pharmacare Holdings has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Aspen Pharmacare Holdings’s data sources below and access millions more through our Disclosure Search.
In 2025, the total operational greenhouse gas (GHG) emissions of Aspen Pharmacare Holdings amounted to 148,281 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Aspen Pharmacare Holdings increased by 5.18%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
In 2025, the total Scope 1 emissions of Aspen Pharmacare Holdings were 32,776 metric tons of CO₂ equivalent (tCO₂e). a
Since 2019, Aspen Pharmacare Holdings's Scope 1 emissions have decreased by 31.85%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2024), Aspen Pharmacare Holdings's Scope 1 emissions remained relatively stable, indicating that Aspen Pharmacare Holdings's emissions have plateaued with no significant change in its operational footprint. a
In 2025, Aspen Pharmacare Holdings reported Scope 2 greenhouse gas (GHG) emissions of 115,505 tCO₂e without specifying the calculation method. a
Since 2019, Aspen Pharmacare Holdings's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 27.31%, reflecting a declining long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2024), Aspen Pharmacare Holdings's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Aspen Pharmacare Holdings 's emissions have plateaued with no significant change in its energy consumption footprint. a
In 2025, Aspen Pharmacare Holdings reported its Scope 2 emissions using an unspecified methodology. a
In 2025, Aspen Pharmacare Holdings reported Scope 1 greenhouse gas (GHG) emissions of 32,776 tCO₂e and total revenues of USD 2,450 millions. This translates into an emissions intensity of 13.38 tCO₂e per millions USD. a
In 2025, Aspen Pharmacare Holdings reported a Scope 1 emissions intensity of 13.38 tCO₂e per millions USD. Compared to the peer group median of 9.47 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
In 2025, Aspen Pharmacare Holdings ranked 15 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Aspen Pharmacare Holdings is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a